36C25222Q0887.docx

Special Notice Special Notice

GENERAL INFORMATION

Great Lakes Acquisition Center (GLAC) 115 S 84th Street, Suite 101

Milwaukee WI 53214-1476

POINT OF CONTACT*

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

The VA Great Lakes Acquisition Center intends to negotiate a sole source contract with The Binding Site of San Diego, CA to provide Optilite System, Reagents, Supplies and Service for Hines VAMC, located in Hines, IL. This contract will be a IDIQ Contract for 5 years. This procurement is being conducted in accordance FAR 13.501, only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. Contract is firm fixed price and the NAICS Code is 325413.

This Notice of Intent is not a request for competitive proposals. No solicitations documents are available and telephone requests will not be honored. However, if a firm believes it can meet the requirements it must furnish information about its products and services, as well as references from other customers who are using these products and service, to the Contracting Officer within seven (7) calendar days from the date of publication of this synopsis. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements. Information must be sent to the Contracting Officer, VAMC GLAC, 115 S. 84th Street, Suite 101, Milwaukee WI 53214 or via fax to (414) 844-4888. (CO: Teresa Beers, teresa.beers@va.gov). Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, the GLAC will proceed with the sole source negotiation with Binding Site.

Edward Hines, Jr. VA Hospital requires free light chain reagents that are FDA 510(k) cleared for the diagnosis and monitoring of the following:

Special Notice